Pfizer Inc. (PFE)
NYSE$26.21
Market Cap
$148.54B
Sector
Healthcare
Industry
Drug Manufacturers—General
Rank in Sector
179 of 924
Rank in Industry
2 of 12
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
PFE Insider Trading Activity
PFE Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $527,312 | 2 | 50 |
Sells | $212,539 | 2 | 50 |
Related Transactions
| BLAYLOCK RONALD E | director | 1 | $499,072 | 0 | $0 | $499,072 |
| Gottlieb Scott | director | 1 | $28,240 | 0 | $0 | $28,240 |
| DAMICO JENNIFER B. | SVP & Controller | 0 | $0 | 2 | $212,539 | $-212,539 |
About Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, …
Insider Activity of Pfizer Inc.
Over the last 12 months, insiders at Pfizer Inc. have bought $527,312 and sold $212,539 worth of Pfizer Inc. stock.
On average, over the past 5 years, insiders at Pfizer Inc. have bought $561,939 and sold $17.32M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BLAYLOCK RONALD E (director) — $499,072. Gottlieb Scott (director) — $28,240.
The last purchase of 19,457 shares for transaction amount of $499,072 was made by BLAYLOCK RONALD E (director) on 2025‑02‑13.
List of Insider Buy and Sell Transactions, Pfizer Inc.
| 2025-03-04 | Sale | DAMICO JENNIFER B. | SVP & Controller | 2,500 <0.0001% | $25.93 | $64,825 | +1.15% | |
| 2025-02-13 | BLAYLOCK RONALD E | director | 19,457 0.0003% | $25.65 | $499,072 | +1.60% | ||
| 2024-10-30 | Gottlieb Scott | director | 1,000 <0.0001% | $28.24 | $28,240 | -6.00% | ||
| 2024-08-13 | Sale | DAMICO JENNIFER B. | SVP & Controller | 5,154 <0.0001% | $28.66 | $147,714 | -5.40% | |
| 2023-12-15 | Gottlieb Scott | director | 3,000 <0.0001% | $26.47 | $79,401 | +7.70% | ||
| 2023-05-08 | Gottlieb Scott | director | 1,000 <0.0001% | $38.58 | $38,580 | -19.06% | ||
| 2023-05-05 | Gottlieb Scott | director | 1,000 <0.0001% | $38.42 | $38,425 | -18.43% | ||
| 2023-03-15 | Sale | DAMICO JENNIFER B. | SVP & Controller | 9,912 0.0002% | $40.02 | $396,678 | -13.65% | |
| 2022-06-07 | Sale | DAMICO JENNIFER B. | SVP & Controller | 4,218 <0.0001% | $53.96 | $227,603 | -14.85% | |
| 2022-05-13 | Sale | SAHNI PAYAL | Executive Vice President | 1,408 <0.0001% | $49.84 | $70,175 | -5.34% | |
| 2022-05-13 | Sale | DAMICO JENNIFER B. | SVP & Controller | 4,000 <0.0001% | $50.50 | $202,000 | -5.34% | |
| 2022-05-12 | Sale | LANKLER DOUGLAS M | Executive Vice President | 38,273 0.0007% | $49.41 | $1.89M | -6.07% | |
| 2022-05-12 | Sale | Carapezzi William R JR | Executive Vice President | 32,908 0.0006% | $50.00 | $1.65M | -6.07% | |
| 2022-05-11 | Sale | Dolsten Mikael | President R&D | 32,015 0.0006% | $49.31 | $1.58M | -3.29% | |
| 2021-12-03 | Sale | JOHNSON RADY A | Executive Vice President | 38,000 0.0007% | $53.42 | $2.03M | -5.94% | |
| 2021-12-02 | Sale | MACKENZIE ALEXANDER R | Executive Vice President | 82,720 0.0015% | $54.26 | $4.49M | -3.78% | |
| 2021-11-26 | Sale | SUSMAN SALLY | Executive Vice President | 88,616 0.0016% | $54.52 | $4.83M | -5.48% | |
| 2021-11-26 | Sale | LANKLER DOUGLAS M | Executive Vice President | 80,000 0.0014% | $54.37 | $4.35M | -5.48% | |
| 2021-11-12 | Sale | Hwang Angela | Group President | 52,340 0.0009% | $49.60 | $2.6M | +2.90% | |
| 2021-11-11 | Sale | YOUNG JOHN D | Group President | 300,000 0.0053% | $50.06 | $15.02M | +1.94% |
Total: 199
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| BLAYLOCK RONALD E | director | 27707 0.0005% | $726,200.47 | 2 | 0 | +2.14% |
| Gottlieb Scott | director | 10000 0.0002% | $262,100.00 | 6 | 0 | <0.0001% |
| SIMMONS DAVID S | Business Unit President | 134404 0.0024% | $3.52M | 1 | 0 | +21.09% |
| SUSMAN SALLY | Executive Vice President | 89575 0.0016% | $2.35M | 1 | 11 | <0.0001% |
| BURT ROBERT N | director | 12200 0.0002% | $319,762.00 | 1 | 0 | +18.68% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$364,217,072 | 28 | 9.11% | $20.7B | |
$6,077,160 | 24 | 3.21% | $392.42B | |
$1,922,773,492 | 23 | 18.03% | $793.48B | |
$28,542,809 | 19 | 26.40% | $374.7B | |
$23,029,445 | 18 | 9.34% | $121.92B |
PFE Institutional Investors: Active Positions
| Increased Positions | 1,293 | +35.08% | 255M | +6.79% |
| Decreased Positions | 1,736 | -47.1% | 263M | -7% |
| New Positions | 337 | New | 66M | New |
| Sold Out Positions | 249 | Sold Out | 20M | Sold Out |
| Total Postitions | 3,243 | -12.02% | 4B | -0.21% |
PFE Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $13.34M | 9.15% | 518.54M | +2M | +0.44% | 2024-12-31 |
| Blackrock, Inc. | $11.62M | 7.97% | 451.74M | +16M | +3.61% | 2024-12-31 |
| State Street Corp | $7.47M | 5.13% | 290.48M | +23,750 | +<0.01% | 2024-12-31 |
| Charles Schwab Investment Management Inc | $4M | 2.74% | 155.46M | +25M | +19.45% | 2024-12-31 |
| Wellington Management Group Llp | $3.6M | 2.47% | 139.99M | -24M | -14.5% | 2024-12-31 |
| Geode Capital Management, Llc | $3.1M | 2.13% | 120.59M | +3M | +2.48% | 2024-12-31 |
| Norges Bank | $2.26M | 1.55% | 87.79M | +4M | +4.55% | 2024-12-31 |
| Massachusetts Financial Services Co /Ma/ | $1.97M | 1.35% | 76.5M | +5M | +7.52% | 2024-12-31 |
| Morgan Stanley | $1.9M | 1.3% | 73.9M | -4M | -5.22% | 2024-12-31 |
| Northern Trust Corp | $1.5M | 1.03% | 58.38M | +4M | +7.69% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.